Delivery Order SPE2DB22D2206-SPE2DB24FDX12

Award Date 10/26/23
Potential Completion Date 10/27/23
Potential Value $4.5K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of pharmaceutical products, specifically NEXLIZET 180-10 MG TABLET, to the Medical Supply Chain component of the Defense Logistics Agency (DLA). The fixed-price contract, valued at $1,861.46, was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical,...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract has a Ceiling Value of $17,883.93 and is a Delivery Order under an Indefinite Delivery Contract (IDC) with the DLA, valued at $999,999,999 and running through November 2026. The IDC provides a comprehensive range of pharmaceutical products and medical supplies, including specialty...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,275.06 firm fixed-price delivery order is for the supply of the medication NEXLIZET 180-10 MG TABLET UU 30S. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
This federal contract award, valued at $1,867.26, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for NEXLIZET 180-10 MG TABLET UU 30S, with an ultimate completion date of October 29, 2024. The contract is a firm fixed-price agreement, without any set-aside requirements. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,135.03, is for the delivery of NEXLIZET 180-10 MG TABLET medical supplies. This award is part of a larger Indefinite Delivery Contract (IDC) with the DLA, valued at $999,999,999 and running through November 2026, which covers a comprehensive range of pharmaceutical products...
This federal contract award, with ID SPE2DB20D3505|SPE2DB25FT8E8, was issued by the Defense Logistics Agency (DLA) to the Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,526.28, is a Firm Fixed Price Delivery Order for the supply of NEXLIZET 180-10 MG TABLET UU 30S, a medical product. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp, the prime contractor, has an Indefinite Delivery Contract...
This federal contract award, valued at $1,834.09, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Nexletol 180 mg tablets and does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 through November 2026. This IDC...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,998.80 firm-fixed-price delivery order is for NEXLETOL 180 MG TABLET, a pharmaceutical product. The contract has a completion date of January 8, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through November 2026, which serves as a...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a Delivery Order valued at $1,262.86 issued by the Defense Logistics Agency (DLA). The contract is for the supply of NEXLETOL 180 MG TABLET UU 30S, a pharmaceutical product. The contract has an ultimate completion date of February 12, 2025 and is a Firm Fixed Price contract type. No set-aside designation was used for this award. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $1,892.62, is for the delivery of a pharmaceutical product, specifically NEXLETOL 180 MG TABLET, and is classified as a Firm Fixed Price Delivery Order. The award is not designated as a set-aside contract. This contract is associated with a larger Indefinite Delivery Contract...
  • SPE2DB22D2206
    Indefinite Delivery Contract
  • SPE2DB22D2206-SPE2DB24FDX12
    Delivery Order

This federal contract award, valued at $4,538.88, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally, including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits across multiple therapeutic domains. The specific contract awarded is for the supply of the drug NEXLIZET 180-10 MG TABLET and has no set-aside designation, indicating open competition.

Generated 5/12/25, 10:23 AM